Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The Duffy antigen/receptor for chemokines (DARC) and prostate cancer. A role as clear as black and white?

FASEB journal : official publication of the Federation of American Societies for Experimental Biology - 1 Jul 2002

Lentsch Alex B

Abstract excerpt

Prostate cancer is the most commonly diagnosed cancer and the second leading cause of cancer-related death among men in the United States. African American men have a 60% greater incidence of prostate cancer and a twofold higher mortality rate than Caucasian men. The Duffy antigen/receptor for chemokines (DARC) is a receptor expressed on erythrocytes and vascular endothelial cells that binds to and clears...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, Protozoan
Share to Black People

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Chemokines, CXC

Share to Duffy Blood-Group System

Share to Neovascularization, Pathologic

Share to Protozoan Proteins

Share to Receptors, Chemokine

Share to Terminology as Topic

Source

Identifiers

PMID: 12087071
DOI: 10.1096/fj.02-0066hyp

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Duffy antigen/receptor for chemokines (DARC) and prostate cancer. A role as clear as black and white?PMID 12087071Read ↗

The Duffy Antigen/Receptor for Chemokines (DARC) and prostate-cancer risk among Jamaican men.Semantic proximity Read ↗

Distribution of Duffy Antigen Receptor for Chemokines (DARC) and Risk of Prostate Cancer in Barbados, West Indies.Semantic proximity Read ↗

Racial Differences in Immunological Landscape Modifiers Contributing to Disparity in Prostate CancerSemantic proximity Read ↗

Biological determinants of health disparities in prostate cancerSemantic proximity Read ↗

The DARC Side of Inflamm-Aging: Duffy Antigen Receptor for Chemokines (DARC/ACKR1) as a Potential Biomarker of Aging, Immunosenescence, and Breast Oncogenesis among High-Risk Subpopulations.Semantic proximity Read ↗

Tracing the Evolution of Sex Hormones and Receptor‐Mediated Immune Microenvironmental Differences in Prostate and Bladder Cancers: From Embryonic Development to DiseaseSemantic proximity Read ↗

Prostate cancer in men of African origin.Semantic proximity Read ↗

Health inequity drives disease biology to create disparities in prostate cancer outcomes.Semantic proximity Read ↗

The Duffy antigen receptor for chemokines, ACKR 1,– ‘Jeanne DARC ’ of benign neutropeniaSemantic proximity Read ↗

Ancestry-Dependent Immunologic and Prognostic Effects Characterize the Prostate Cancer Urinary ProteomeSemantic proximity Read ↗

The Duffy antigen/receptor for chemokines (DARC) is expressed in endothelial cells of Duffy negative individuals who lack the erythrocyte receptor.Semantic proximity Read ↗

Duffy antigen receptor for chemokines mediates trans-infection of HIV-1 from red blood cells to target cells and affects HIV-AIDS susceptibility.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.